Man Group PLC Omeros Corp Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $6,820 - $14,355	-2,750 Reduced 6.66%	38,545 $179,000
Q4 2022 Feb 14, 2023	BUY	$1.75 - $3.96 $46,973 - $106,294	26,842 Added 185.72%	41,295 $93,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $44,659 - $107,819	14,453 New	14,453 $45,000
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $125,767 - $196,276	-11,732 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $208,008 - $313,127	11,732 New	11,732 $286,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.